OSCR

Synthetic dataset of PLGA and liposome nanocarrier formulations for brain-cancer-relevant drug delivery, release, blood-brain-barrier transport, and paired cell-viability proxies.

Overview

  1. Automotive & Robotics Program, Computer Engineering Department, BINUS ASO School of Engineering, Bina Nusantara University, Jakarta 11480, Indonesia
  2. Computer Science Department, School of Computer Science, Bina Nusantara University, Jakarta 11480, Indonesia
Institutions: Binus University (Indonesia)
Journal: Data in brief, volume 67, article 112926
Dates: received 21 April 2026; accepted 30 May 2026; published online 1 June 2026
Type: Data paper · Language: English
License: CC BY-NC
Identifiers: DOI 10.1016/j.dib.2026.112926 · PMID 42317624 · PMCID PMC13272574 · OpenAlex W7163041888
Open access: gold, a free copy (OpenAlex)
Categories: none (in silico) (organism), other condition (population), methods / tools (subfield)
Keywords: Synthetic data, PLGA nanoparticles, Liposomes, Nanocarriers, Blood-brain barrier, Brain cancer drug delivery, Machine learning benchmark, Materials informatics
Journal subjects: Data Article
Topic: Nanoparticle-Based Drug Delivery (Biomaterials, Materials Science), according to OpenAlex
Citations: not cited yet (Europe PMC); 9 references in the paper

Abstract

This data article describes an original synthetic/simulated dataset designed to support materials-informatics and comparative formulation analysis of PLGA nanoparticles and liposomes for brain-cancer-relevant drug delivery. Open row-level datasets that jointly cover formulation descriptors, release kinetics, blood-brain-barrier transport proxies, and paired tumor/non-tumor cell-assay outcomes for PLGA and liposome carriers were not identified by us in a single harmonized open resource during preparation of this package, motivating a transparent synthetic benchmark for methodological and machine-learning reuse. The dataset was inspired by the scientific themes synthesized in the related review article by Makalew and Abrori, but it does not reproduce bibliometric records, published tables, or experimental rows. The package contains 6000 unique virtual formulations in a formulation master table and three linked long-format data tables describing time-resolved release profiles (360,000 rows), blood-brain-barrier-related transport proxies (54,000 rows), and paired tumor/non-tumor cell-assay proxies (432,000 rows), totaling approximately 846,000 assay-like rows. Variables include composition descriptors, preparation routes, physicochemical properties, targeting features, encapsulation efficiency, drug loading, stability, biodegradation proxy, serum stability proxy, integrated blood-brain-barrier transport score, cellular uptake score, biocompatibility score, tumor-directed cytotoxicity proxy, off-target toxicity proxy, and derived multi-criteria performance scores. The synthetic data were generated with a transparent, reproducible workflow that combines domain-informed priors, hierarchical conditional rules, latent heterogeneity, batch effects, replicate variation, bounded noise, sparse scientifically motivated missingness, and post-generation quality filters. The dataset is distributed in open tabular formats together with generation code, a codebook, validation documentation, and reproducible figure-generation scripts.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability

Mendeley DataSynthetic dataset of PLGA and liposome nanocarrier formulations for brain-cancer-relevant drug delivery, release, blood-brain-barrier transport, and paired cell-viability proxies (Original data) (https://10.17632/jvfb9mjzws.1).

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 2 authors, 8 keywords, 9 references.

Cite

This paper

Abrori, S., & Makalew, B. (2026). Synthetic dataset of PLGA and liposome nanocarrier formulations for brain-cancer-relevant drug delivery, release, blood-brain-barrier transport, and paired cell-viability proxies. Data in brief, 67, 112926. https://doi.org/10.1016/j.dib.2026.112926

BibTeX

@article{abrori2026synthetic,
author = {Abrori, Syauqi and Makalew, Brilly},
title = {{Synthetic dataset of PLGA and liposome nanocarrier formulations for brain-cancer-relevant drug delivery, release, blood-brain-barrier transport, and paired cell-viability proxies}},
journal = {Data in brief},
year = {2026},
month = jun,
volume = {67},
pages = {112926},
publisher = {Elsevier},
issn = {2352-3409},
doi = {10.1016/j.dib.2026.112926},
url = {https://doi.org/10.1016/j.dib.2026.112926},
pmid = {42317624},
pmcid = {PMC13272574}
}

RIS

TY - JOUR
AU - Abrori, Syauqi
AU - Makalew, Brilly
TI - Synthetic dataset of PLGA and liposome nanocarrier formulations for brain-cancer-relevant drug delivery, release, blood-brain-barrier transport, and paired cell-viability proxies
T2 - Data in brief
J2 - Data Brief
PY - 2026
DA - 2026/06/01
VL - 67
SP - 112926
SN - 2352-3409
PB - Elsevier
DO - 10.1016/j.dib.2026.112926
UR - https://doi.org/10.1016/j.dib.2026.112926
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.dib.2026.112926",
"type": "article-journal",
"title": "Synthetic dataset of PLGA and liposome nanocarrier formulations for brain-cancer-relevant drug delivery, release, blood-brain-barrier transport, and paired cell-viability proxies",
"container-title": "Data in brief",
"author": [
{
"family": "Abrori",
"given": "Syauqi"
},
{
"family": "Makalew",
"given": "Brilly"
}
],
"container-title-short": "Data Brief",
"volume": "67",
"page": "112926",
"DOI": "10.1016/j.dib.2026.112926",
"PMID": "42317624",
"PMCID": "PMC13272574",
"ISSN": "2352-3409",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.dib.2026.112926",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1016/j.ibneur.2023.12.002 [code]
Evaluating synthetic neuroimaging data augmentation for automatic brain tumour segmentation with a deep fully-convolutional network.
Journal: IBRO neuroscience reports
In common: none (in silico), other condition, 1 reference
[2] doi:10.1002/mrm.70488 [code]
Advancing the Volumetric Analysis of Ultra-Low-Field Brain MRI Using Image-to-Image Translation.
Journal: Magnetic resonance in medicine
In common: methods / tools, 1 reference
[3] doi:10.1038/s41597-024-04157-4 [code]
Generative models of MRI-derived neuroimaging features and associated dataset of 18,000 samples.
Journal: Scientific data
In common: methods / tools, 1 reference
[4] doi:10.1038/s41592-023-01838-7 [code]
Rapid detection of neurons in widefield calcium imaging datasets after training with synthetic data.
Journal: Nature methods
In common: methods / tools, 1 reference
[5] doi:10.1016/j.isci.2026.117147 [code]
Penetrating potential evaluation of cyclotriphosphazenes target blood-brain barrier via computational toxicology methods.
Journal: iScience
In common: methods / tools, 1 reference
[6] doi:10.1093/gigascience/giaf116 [code]
DUNE: a versatile neuroimaging encoder captures brain complexity across 3 major diseases: cancer, dementia, and schizophrenia.
Journal: GigaScience
In common: other condition, 1 reference
[7] doi:10.1016/j.mtbio.2026.103307
A blood-brain barrier model based on flexible tubes to tailor the biophysical and chemical environment for drug delivery testing.
Journal: Materials today. Bio
In common: 1 reference
[8] doi:10.1038/s41467-026-74888-y
Engineered zwitterion-nanodelivery for precision targeting of brain metastases.
Journal: Nature communications
In common: other condition, 1 reference
[9] doi:10.1186/s13321-026-01191-9 [code]
Multiscale analysis and optimal glioma therapeutic candidate discovery using the CANDO platform.
Journal: Journal of cheminformatics
In common: other condition, 1 reference
[10] doi:10.1186/s13073-024-01410-8
Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target.
Journal: Genome medicine
In common: other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.